Market Research Report

Global mRNA Vaccines and Therapeutics Market Research Report: Forecast (2021-2026)

By mRNA Type (Nucleoside-Modified mRNA (modRNA), Unmodified mRNA, Self-Amplifying mRNA), By Application Type (COVID mRNA Application [Commercialised Vaccine {mRNA-1273, BNT162b2},......Pipeline Vaccines {CVnCoV, LUNAR-COV19, MRT5500, DS-5670}] Non-COVID mRNA Application [Immuno-Oncology, Cardiology, Endocrinology, Haematology, Other infectious & rare diseases]), By End-User (Hospitals & healthcare Clinics, Research Organisation & Institutions, Others), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa), By Country (U.S, Canada, Brazil, Argentina, Mexico, Germany, France, The U.K, Spain, Italy, China, India, Japan, Australia, South Korea, Saudi Arabia, UAE, South Africa), By Competitors (Arcturus Therapeutics Holdings Inc., BioNTech, CureVac N.V., ethris GmbH, Gennova Biopharmaceuticals Ltd, GlaxoSmithKline plc, Moderna, Pantherna Therapeutics GmbH, Pfizer, Providence Therapeutics, Providence Therapeutics, Silence Therapeutics, Translate Bio, Versameb AG, Verve Therapeutics, Inc.) Read more

  • Healthcare
  • Jul 2021
  • Pages 232
  • Report Format: PDF, Excel, PPT

US Reciprocal Tax Impact on Markets: Stay Informed with Expert Insights and Real-Time Updates

Messenger Ribonucleic Acid, also called mRNA vaccine, is a single protein-coding gene in the genome that works as a basis for protein synthesis inside the cells. mRNA vaccines don't consist of the live virus and, instead, they teach cells to make a protein to initiate an immune response.

The “Global mRNA Vaccines and Therapeutics Market” is likely to grow at a CAGR of around 13% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth essentially attributes to the rising prevalence of infectious and chronic diseases, including HIV, diabetes, cancer, and cardiovascular diseases.

Additionally, the inability of the traditional vaccine approaches to perform at a critical time boosts the market growth. Further, technological advancements support the growth of the market as mRNA vaccines and therapeutics are developed with the help of advanced technologies so that these vaccines are highly effective in crucial times.

The research report, “Global mRNA Vaccines and Therapeutics Market Analysis, 2021,” depicts a deep-dive market analysis of market statistics. It primarily consists of regional & country-wise market size, market forecast, CAGR & share of different market segments, competitive benchmarking, and key market drivers & restraints.

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
CAGR (2021-2026) 13%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy
Asia-Pacific: China, India, Japan, South Korea, Australia
South America: Brazil, and Argentina
Middle East & Africa:  UAE, Saudi Arabia, South Africa
Key Companies Profiled Arcturus Therapeutics Holdings Inc., BioNTech, CureVac N.V., ethris GmbH, Gennova Biopharmaceuticals Ltd, GlaxoSmithKline plc, Moderna, Pantherna Therapeutics GmbH, Pfizer, Providence Therapeutics, Providence Therapeutics, Silence Therapeutics, Translate Bio, Versameb AG, Verve Therapeutics, Inc.
Unit Denominations USD Million/Billion

 

COVID-19 pandemic Positively Impacted the Global mRNA Vaccines and Therapeutics Market

The COVID-19 pandemic has positively influenced the growth of the Global mRNA Vaccines and Therapeutics Market owing to the increasing number of COVID-19 patients globally and the massive external funding for the production of mRNA-based COVID-19 vaccines. Additionally, with the emergence of new variants of the SARS-COVID-19 virus across different countries worldwide, the demand for mRNA vaccines is significantly increasing as it is highly effective against new strains. However, as the impact of the COVID-19 pandemic declines in the next few years, the market for mRNA vaccines will drop, which is very likely to affect the overall market growth in the years to come.


Global mRNA Vaccines and Therapeutics Market Research Report: Forecast (2021-2026)

Market Segmentation

Infectious Diseases to Dominate the Global mRNA Vaccines and Therapeutics Market 

Based on Application Type, the market bifurcates into COVID mRNA Application and Non-COVID mRNA Application. Here, Non-COVID mRNA Application segments into Immuno-Oncology, Cardiology, Endocrinology, Haematology, and Other Infectious & Rare Diseases. Of them all, Infectious diseases accounted for more than 80% share in the Global mRNA Vaccines and Therapeutics Market. The mRNA Vaccine encodes the desired antigens from the mRNA sequence. When the mRNA vaccine gets injected, some information gets transferred to the cell to generate specific proteins in the cytoplasm. This protein initiates immune responses in the body and protects the body against diseases. Hence, the mRNA vaccine helps prevent transmission of various infectious diseases like HIV, Ebola, Influenza, and other Infectious Diseases, thereby likely to accelerate the segment growth in the forecast period, cites MarkNtel Advisors in their research report, “Global mRNA Vaccines and Therapeutics Market Analysis, 2021.”

Hospitals and Healthcare Clinics Accounted for the Largest Market Share

Based on End-Users, the market bifurcates into Hospitals & Healthcare Clinics, Research Organization & Institutions, and Others. Among these segments, Hospitals & healthcare Clinics acquired the largest share in the Global mRNA Vaccines and Therapeutics Market in the previous few years. The segment growth primarily owes to the rising patient footfall in hospitals and clinics. Additionally, an increasing number of patients suffering from respiratory diseases, cancer, and infectious diseases also leads to aiding the growth of Hospitals & Healthcare Clinics.

Regional Landscape

North America Attained the Highest Market Share 

Geographically, North America held the largest share in the Global mRNA Vaccines and Therapeutics Market in the past few years, owing to the abundant presence of prominent players & exponentially surging number of COVID-19 patients in the US. Additionally, mounting fund infusions, rising focus on precision medicines, favorable regulatory environment, and snowballing need to develop transformative therapeutics are other critical factors augmenting the market growth in North America.

Market Driver

Increasing Cases of COVID-19

mRNA vaccines help protect against various infectious diseases. The COVID-19 mRNA vaccines teach the cells to make a harmless piece of the spike protein. The spike protein lies on the surface of the COVID-19 virus. Once the mRNA vaccine gets injected, the body starts triggering an immune response, thereby creating antibodies against the virus. Moreover, mRNA vaccines are highly effective in combatting new variants of the COVID-19 virus. Hence, the increasing number of COVID-19 patients leads to accelerate the demand for mRNA vaccines and therapeutics.

Market Challenge

Transportation Challenges Associated with COVID-19 Vaccines 

Transporting mRNA vaccines from the manufacturing site to vaccination centers is one of the biggest challenges for the logistic industry as these vaccines are time-sensitive and temperature-critical products. Therefore, issues while maintaining a cold supply chain to ensure its stability and lack of proper infrastructure to stockpile mRNA-based COVID-19 vaccines are the major factors restraining the market growth.

Competitive Landscape

According to MarkNtel Advisors, the major leading players in the Global mRNA Vaccines and Therapeutics market are Arcturus Therapeutics Holdings Inc., BioNTech, CureVac N.V., ethris GmbH, Gennova Biopharmaceuticals Ltd, GlaxoSmithKline plc, Moderna, Pantherna Therapeutics GmbH, Pfizer, Providence Therapeutics, Providence Therapeutics, Silence Therapeutics, Translate Bio, Versameb AG, Verve Therapeutics, Inc.

Key Questions Answered in the Market Research Report:

  1. What are the overall market statistics or estimates (Market Overview, Market Size- by Value, Forecast Numbers, Market Segmentation, and Market Shares) of the Global mRNA Vaccines and Therapeutics Market?
  2. What are the region-wise industry size, growth drivers, and challenges?
  3. What are the key innovations, opportunities, current & future trends, and regulations in the Global mRNA Vaccines and Therapeutics Market? 
  4. Who are the key competitors, their key strengths & weaknesses, and how they perform in the Global mRNA Vaccines and Therapeutics Market based on a competitive benchmarking matrix?
  5. What are the key results derived from the market surveys conducted during the Global mRNA Vaccines and Therapeutics Market study?

Market Outlook, Segmentation, and Statistics 

  • Impact of COVID-19 on Global mRNA Vaccines and Therapeutics Market
  • Market Size & Analysis
    • By Revenue
  • Market Share & Analysis
    • By mRNA Type
      • Nucleoside-Modified mRNA (modRNA)
      • Unmodified mRNA
      • Self-Amplifying mRNA
    • By Application Type
      • COVID mRNA Application
      • Commercialized Vaccine
      • mRNA-1273
      • BNT162b2
      • Pipeline Vaccines
      • CVnCoV
      • LUNAR-COV19
      • MRT5500
      • DS-5670
      • Non-COVID mRNA Application
      • Immuno-Oncology
      • Cardiology
      • Endocrinology
      • Haematology
      • Other infectious & rare diseases
    • By End Users
      • Hospitals & healthcare Clinics
      • Research Organization & Institutions
      • Others
    • By Region
      • North America
      • South America
      • Europe
      • Middle East & Africa
      • Asia-Pacific
    • By Competitors
      • Competition Characteristics
      • Market Share & Analysis
      • Competitive Metrix
  • Global mRNA Vaccines and Therapeutics Market Hotspots & Opportunities
  • Global mRNA Vaccines and Therapeutics Market Regulations & Policy
  • Key Strategic Imperatives for Success and Growth
  • Global Competition Outlook
  • Competition Matrix
  • Company Profile

Don't Need a Global Report? Focus on reports for specific countries and regions

Frequently Asked Questions

   A. The Global mRNA Vaccines and Therapeutics Market is forecast to grow at a CAGR of 13% during 2021-26.

   A. Arcturus Therapeutics Holdings Inc., BioNTech, CureVac N.V., ethris GmbH, Gennova Biopharmaceuticals Ltd, GlaxoSmithKline plc, Moderna, Pantherna Therapeutics GmbH, Pfizer, Providence Therapeutics, Providence Therapeutics, Silence Therapeutics, and Verve Therapeutics, Inc. are a few leading players in the Global mRNA Vaccines and Therapeutics Market.

   A. The Hospitals and Healthcare Clinics segment is likely to attain the highest CAGR during the forecast period and maintain its significant market share.

   A. North America continues to grow at the highest CAGR during 2021-26, thereby presenting immense opportunities to market players of the Global mRNA Vaccines and Therapeutics Market.

   A. The rising prevalence of infectious & chronic diseases, including HIV, diabetes, cancer, & cardiovascular diseases, technology advancements, and the inability of the traditional vaccine approaches to perform at a critical time are the prime factors fueling the market growth.

   A. The widespread pandemic has also pushed the mRNA Vaccines and Therapeutics market into action by generating new opportunities to develop COVID-19 vaccines, thereby propelling the market growth in the forecast period.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
    4. Market Segmentation
  2. Executive Summary
  3. Impact of COVID-19 on Global mRNA Vaccines and Therapeutics Market
  4. Global mRNA Vaccines and Therapeutics Market Analysis Trends & Insights
  5. Global mRNA Vaccines and Therapeutics Market Intellectual Property Rights Analysis
  6. Global mRNA Vaccines and Therapeutics Market Analysis Hotspots & Opportunities
  7. Global mRNA Vaccines and Therapeutics Market Analysis Government Regulations
  8. Global mRNA Vaccines and Therapeutics Market Use Case Scenario Comparison (COVID-19 vs Non COVID-19)
  9. Global mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
        1. Nucleoside-Modified mRNA (modRNA)
        2. Unmodified mRNA
        3. Self-Amplifying mRNA
      2. By Application Type
        1. COVID mRNA Application
          1. Commercialised Vaccine
            1. mRNA-1273
            2. BNT162b2
          2. Pipeline Vaccines
            1. CVnCoV
            2. LUNAR-COV19
            3. MRT5500
            4. DS-5670
        2. Non-COVID mRNA Application
          1. Immuno-Oncology
          2. Cardiology
          3. Endocrinology
          4. Haematology
          5. Other infectious & rare diseases
      3. By End Users
        1. Hospitals & healthcare Clinics
        2. Research Organisation & Institutions
        3. Others
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. Asia-Pacific
        5. Middle East & Africa
      5. By Competitor
        1. Competition Characteristics
        2. Competitor Alignment in Competition Matrix
  10. North America mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. The US mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. Canada mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        3. Mexico mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  11. South America mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. Brazil mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. Argentina mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  12. Europe mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. The UK mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. Germany mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        3. France mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        4. Italy mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        5. Spain mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  13. Asia-Pacific mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. China mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. India mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        3. Japan mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        4. South Korea mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        5. Australia mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  14. Middle East & Africa mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By mRNA Type
      2. By Application Type
      3. By End User
      4. By Country
        1. UAE mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        2. Saudi Arabia mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
        3. South Africa mRNA Vaccines and Therapeutics Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. By Revenues
          2. Market Share & Analysis
            1. By mRNA Type
            2. By Application Type
            3. By End User
  15. Global mRNA Vaccines and Therapeutics Market Analysis Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  16. Global mRNA Vaccines and Therapeutics Market Key Strategic Imperatives for Success & Growth
  17. Competitive Benchmarking
    1. Competition Matrix
      1. Product Portfolio
      2. Target Markets
      3. Target Security Type
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Company Profiles (Business Description, Product Offering, Target Markets, Assets, Strategic Alliances or Partnerships, etc.)
      1. Arcturus Therapeutics Holdings Inc.
      2. BioNTech
      3. CureVac N.V.
      4. ethris GmbH
      5. Gennova Biopharmaceuticals Ltd
      6. GlaxoSmithKline plc
      7. Moderna
      8. Pantherna Therapeutics GmbH
      9. Pfizer
      10. Providence Therapeutics
      11. Providence Therapeutics
      12. Silence Therapeutics
      13. Translate Bio
      14. Versameb AG
      15. Verve Therapeutics, Inc.
  18. Disclaimer


Global MRNA Vaccines And Therapeutics Market Segmentation

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Request Sample Talk to our Consultant Request Customization
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Related Reports